Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grounds

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Neuromuscular Disorders : NMD|November 9, 2010
Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal miceA T Piers, T Lavin, H G Radley-Crabb, et al.
Growth Factors (Chur, Switzerland)|January 1, 1993
Comparison of basic fibroblast growth factor in X-linked dystrophin-deficient myopathies of human, dog and mouseJ E Anderson, B A Kakulas, P F Jacobsen, et al.
The FEBS Journal|January 22, 2013
Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathiesJessica R Terrill, Hannah G Radley-Crabb, Tomohito Iwasaki, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 31, 2013
Quantitative assessment of muscle damage in the mdx mouse model of Duchenne muscular dystrophy using polarization-sensitive optical coherence tomographyXiaojie Yang, Lixin Chin, Blake R Klyen, et al.
Molecular and Cellular Neurosciences|September 5, 2020
Dystrophic Dmd<sup>mdx</sup> rats show early neuronal changes (increased S100β and Tau5) at 8 months, supporting severe dystropathology in this rodent model of Duchenne muscular dystrophyVidya S Krishnan, Lakshana P Thanigaiarasu, Robert White, et al.
Plos One|March 4, 2014
Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophyHannah G Radley-Crabb, Juan C Marini, Horacio A Sosa, et al.
Skeletal Muscle|May 23, 2026
Insights into the heterogeneous muscle lipidome of dysferlin-deficient mice: effects of age, muscle type, and sexStacey N Keenan, Jackie Bayliss, Olivia Lee, et al.
Skeletal Muscle|April 24, 2025
Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse modelSai Yarlagadda, Chynna-Loren Sheremeta, Sang Won Cheung, et al.
Frontiers in Genetics|December 4, 2018
MicroRNA and Long Non-coding RNA Regulation in Skeletal Muscle From Growth to Old Age Shows Striking Dysregulation of the Callipyge LocusJasmine Mikovic, Kate Sadler, Lauren Butchart, et al.
Journal of Lipid Research|June 17, 2019
Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in miceVanessa R Haynes, Stacey N Keenan, Jackie Bayliss, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Neuromuscular Disorders : NMD|November 9, 2010
Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal miceA T Piers, T Lavin, H G Radley-Crabb, et al.
Growth Factors (Chur, Switzerland)|January 1, 1993
Comparison of basic fibroblast growth factor in X-linked dystrophin-deficient myopathies of human, dog and mouseJ E Anderson, B A Kakulas, P F Jacobsen, et al.
The FEBS Journal|January 22, 2013
Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathiesJessica R Terrill, Hannah G Radley-Crabb, Tomohito Iwasaki, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 31, 2013
Quantitative assessment of muscle damage in the mdx mouse model of Duchenne muscular dystrophy using polarization-sensitive optical coherence tomographyXiaojie Yang, Lixin Chin, Blake R Klyen, et al.
Molecular and Cellular Neurosciences|September 5, 2020
Dystrophic Dmd<sup>mdx</sup> rats show early neuronal changes (increased S100β and Tau5) at 8 months, supporting severe dystropathology in this rodent model of Duchenne muscular dystrophyVidya S Krishnan, Lakshana P Thanigaiarasu, Robert White, et al.
Plos One|March 4, 2014
Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophyHannah G Radley-Crabb, Juan C Marini, Horacio A Sosa, et al.
Skeletal Muscle|May 23, 2026
Insights into the heterogeneous muscle lipidome of dysferlin-deficient mice: effects of age, muscle type, and sexStacey N Keenan, Jackie Bayliss, Olivia Lee, et al.
Skeletal Muscle|April 24, 2025
Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse modelSai Yarlagadda, Chynna-Loren Sheremeta, Sang Won Cheung, et al.
Frontiers in Genetics|December 4, 2018
MicroRNA and Long Non-coding RNA Regulation in Skeletal Muscle From Growth to Old Age Shows Striking Dysregulation of the Callipyge LocusJasmine Mikovic, Kate Sadler, Lauren Butchart, et al.
Journal of Lipid Research|June 17, 2019
Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in miceVanessa R Haynes, Stacey N Keenan, Jackie Bayliss, et al.
Pageof 20